New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2016 Feb 14

PMID 26873446

Citations 22

Authors

Natallia Makarava

Regina Savtchenko

Irina Alexeeva

Robert G Rohwer

Ilia V Baskakov

Affiliations

Soon will be listed here.

Abstract

Previous studies established that transmissible prion diseases could be induced by in vitro-produced recombinant prion protein (PrP) fibrils with structures that are fundamentally different from that of authentic PrP scrapie isoform (PrP(Sc)). To explain evolution of synthetic prions, a new mechanism referred to as deformed templating was introduced. Here, we asked whether an increase in expression level of the cellular form of PrP (PrP(C)) speeds up the evolution of synthetic strains in vivo. We found that in transgenic mice that overexpress hamster PrP(C), PrP(C) overexpression accelerated recombinant PrP fibril-induced conversion of PrP(C) to the abnormal proteinase K-resistant state, referred to as atypical PrPres, which was the first product of PrP(C) misfolding in vivo. However, overexpression of PrP(C) did not facilitate the second step of synthetic strain evolution-transition from atypical PrPres to PrP(Sc), which is attributed to the stochastic nature of rare deformed templating events. In addition, the potential of atypical PrPres to interfere with replication of a short-incubation time prion strain was investigated. Atypical PrPres was found to interfere strongly with replication of 263K in vitro; however, it did not delay prion disease in animals. The rate of deformed templating does not depend on the concentration of substrate and is hence more likely to be controlled by the intrinsic rate of conformational errors in templating alternative self-propagating states.

Citing Articles

Prions: structure, function, evolution, and disease.

Casey C, Sleator R Arch Microbiol. 2024; 207(1):1.

PMID: 39572454 DOI: 10.1007/s00203-024-04200-3.

Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.

Igel A, Fornara B, Rezaei H, Beringue V Cell Tissue Res. 2022; 392(1):149-166.

PMID: 36399162 PMC: 10113350. DOI: 10.1007/s00441-022-03700-2.

Prion strains: shining new light on old concepts.

Block A, Bartz J Cell Tissue Res. 2022; 392(1):113-133.

PMID: 35796874 PMC: 11318079. DOI: 10.1007/s00441-022-03665-2.

Role of sialylation of N-linked glycans in prion pathogenesis.

Makarava N, Baskakov I Cell Tissue Res. 2022; 392(1):201-214.

PMID: 35088180 PMC: 9329487. DOI: 10.1007/s00441-022-03584-2.

From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases.

Baskakov I Int J Mol Sci. 2021; 22(2).

PMID: 33477465 PMC: 7830165. DOI: 10.3390/ijms22020901.

References

Breydo L, Sun Y, Makarava N, Lee C, Novitskaia V, Bocharova O . Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation. Biochemistry. 2007; 46(3):852-61. PMC: 2522369. DOI: 10.1021/bi061923v. View

Makarava N, Kovacs G, Savtchenko R, Alexeeva I, Budka H, Rohwer R . Stabilization of a prion strain of synthetic origin requires multiple serial passages. J Biol Chem. 2012; 287(36):30205-14. PMC: 3436274. DOI: 10.1074/jbc.M112.392985. View

Schutt C, Bartz J . Prion interference with multiple prion isolates. Prion. 2008; 2(2):61-3. PMC: 2634519. DOI: 10.4161/pri.2.2.6806. View

Colby D, Wain R, Baskakov I, Legname G, Palmer C, Nguyen H . Protease-sensitive synthetic prions. PLoS Pathog. 2010; 6(1):e1000736. PMC: 2809756. DOI: 10.1371/journal.ppat.1000736. View

Legname G, Baskakov I, Nguyen H, Riesner D, Cohen F, DeArmond S . Synthetic mammalian prions. Science. 2004; 305(5684):673-6. DOI: 10.1126/science.1100195. View

Biacabe A, Jacobs J, Bencsik A, Langeveld J, Baron T . H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases. Prion. 2009; 1(1):61-8. PMC: 2633710. DOI: 10.4161/pri.1.1.3828. View

Cohen F, Prusiner S . Pathologic conformations of prion proteins. Annu Rev Biochem. 1998; 67:793-819. DOI: 10.1146/annurev.biochem.67.1.793. View

Klimova N, Makarava N, Baskakov I . The diversity and relationship of prion protein self-replicating states. Virus Res. 2014; 207:113-9. PMC: 4395513. DOI: 10.1016/j.virusres.2014.10.002. View

Jackson W, Borkowski A, Faas H, Steele A, King O, Watson N . Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron. 2009; 63(4):438-50. PMC: 2775465. DOI: 10.1016/j.neuron.2009.07.026. View

10.

Makarava N, Kovacs G, Bocharova O, Savtchenko R, Alexeeva I, Budka H . Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 2010; 119(2):177-87. PMC: 2808531. DOI: 10.1007/s00401-009-0633-x. View

11.

Prusiner S, Scott M . Genetics of prions. Annu Rev Genet. 1997; 31:139-75. DOI: 10.1146/annurev.genet.31.1.139. View

12.

Makarava N, Savtchenko R, Baskakov I . Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification. J Biol Chem. 2012; 288(1):33-41. PMC: 3537030. DOI: 10.1074/jbc.M112.419531. View

13.

Gonzalez-Montalban N, Makarava N, Savtchenko R, Baskakov I . Relationship between conformational stability and amplification efficiency of prions. Biochemistry. 2011; 50(37):7933-40. PMC: 3183828. DOI: 10.1021/bi200950v. View

14.

Ostapchenko V, Sawaya M, Makarava N, Savtchenko R, Nilsson K, Eisenberg D . Two amyloid States of the prion protein display significantly different folding patterns. J Mol Biol. 2010; 400(4):908-21. PMC: 2908243. DOI: 10.1016/j.jmb.2010.05.051. View

15.

Kovacs G, Makarava N, Savtchenko R, Baskakov I . Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles. Am J Pathol. 2013; 183(5):1539-1547. PMC: 3814526. DOI: 10.1016/j.ajpath.2013.07.024. View

16.

Colby D, Zhang Q, Wang S, Groth D, Legname G, Riesner D . Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A. 2007; 104(52):20914-9. PMC: 2409241. DOI: 10.1073/pnas.0710152105. View

17.

Lawson V, Priola S, Meade-White K, Lawson M, Chesebro B . Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro. J Biol Chem. 2004; 279(14):13689-95. DOI: 10.1074/jbc.M303697200. View

18.

Rodriguez-Martinez A, de Munain A, Ferrer I, Zarranz J, Atares B, Villagra N . Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt-Jakob disease: a case report. J Med Case Rep. 2012; 6:348. PMC: 3514380. DOI: 10.1186/1752-1947-6-348. View

19.

Makarava N, Ostapchenko V, Savtchenko R, Baskakov I . Conformational switching within individual amyloid fibrils. J Biol Chem. 2009; 284(21):14386-95. PMC: 2682887. DOI: 10.1074/jbc.M900533200. View

20.

Bartz J, Kramer M, Sheehan M, Hutter J, Ayers J, Bessen R . Prion interference is due to a reduction in strain-specific PrPSc levels. J Virol. 2006; 81(2):689-97. PMC: 1797475. DOI: 10.1128/JVI.01751-06. View